ID   NLGN1_RAT               Reviewed;         843 AA.
AC   Q62765;
DT   23-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 189.
DE   RecName: Full=Neuroligin-1;
DE   AltName: Full=Neuroligin I;
DE   Flags: Precursor;
GN   Name=Nlgn1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), PARTIAL PROTEIN
RP   SEQUENCE, CHARACTERIZATION, AND INTERACTION WITH NEUREXIN 1-BETA.
RC   TISSUE=Brain;
RX   PubMed=7736595; DOI=10.1016/0092-8674(95)90396-8;
RA   Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C.,
RA   Suedhof T.C.;
RT   "Neuroligin 1: a splice site-specific ligand for beta-neurexins.";
RL   Cell 81:435-443(1995).
RN   [2]
RP   INTERACTION WITH NEUREXIN 1-BETA, AND FUNCTION.
RX   PubMed=9325340; DOI=10.1074/jbc.272.41.26032;
RA   Nguyen T., Suedhof T.C.;
RT   "Binding properties of neuroligin 1 and neurexin 1beta reveal function as
RT   heterophilic cell adhesion molecules.";
RL   J. Biol. Chem. 272:26032-26039(1997).
RN   [3]
RP   BLOCKAGE OF N-TERMINUS, AND INTERACTION WITH NEUREXIN 1-BETA; NEUREXIN
RP   2-BETA AND NEUREXIN 3-BETA.
RX   PubMed=8576240; DOI=10.1074/jbc.271.5.2676;
RA   Ichtchenko K., Nguyen T., Suedhof T.C.;
RT   "Structures, alternative splicing, and neurexin binding of multiple
RT   neuroligins.";
RL   J. Biol. Chem. 271:2676-2682(1996).
RN   [4]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=9927700; DOI=10.1073/pnas.96.3.1100;
RA   Song J.-Y., Ichtchenko K., Suedhof T.C., Brose N.;
RT   "Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory
RT   synapses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:1100-1105(1999).
RN   [5]
RP   INTERACTION WITH AIP1.
RX   PubMed=9694864; DOI=10.1074/jbc.273.33.21105;
RA   Hirao K., Hata Y., Ide N., Takeuchi M., Irie M., Yao I., Deguchi M.,
RA   Toyoda A., Suedhof T.C., Takai Y.;
RT   "A novel multiple PDZ domain-containing molecule interacting with N-methyl-
RT   d-aspartate receptors and neuronal cell adhesion proteins.";
RL   J. Biol. Chem. 273:21105-21110(1998).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=11329178; DOI=10.1002/glia.1050;
RA   Gilbert M., Smith J., Roskams A.J., Auld V.J.;
RT   "Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory
RT   ensheathing glia, a growth-promoting class of macroglia.";
RL   Glia 34:151-164(2001).
RN   [7]
RP   DISULFIDE BONDS, AND GLYCOSYLATION.
RX   PubMed=14769026; DOI=10.1021/bi035278t;
RA   Hoffman R.C., Jennings L.L., Tsigelny I., Comoletti D., Flynn R.E.,
RA   Suedhof T.C., Taylor P.;
RT   "Structural characterization of recombinant soluble rat neuroligin 1:
RT   mapping of secondary structure and glycosylation by mass spectrometry.";
RL   Biochemistry 43:1496-1506(2004).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15620359; DOI=10.1016/j.cell.2004.11.035;
RA   Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M.;
RT   "Neurexins induce differentiation of GABA and glutamate postsynaptic
RT   specializations via neuroligins.";
RL   Cell 119:1013-1026(2004).
RN   [9]
RP   INTERACTION WITH PDZRN3.
RX   PubMed=15458844; DOI=10.1016/j.neuropharm.2004.06.023;
RA   Meyer G., Varoqueaux F., Neeb A., Oschlies M., Brose N.;
RT   "The complexity of PDZ domain-mediated interactions at glutamatergic
RT   synapses: a case study on neuroligin.";
RL   Neuropharmacology 47:724-733(2004).
RN   [10]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=18755801; DOI=10.1210/en.2008-0274;
RA   Suckow A.T., Comoletti D., Waldrop M.A., Mosedale M., Egodage S.,
RA   Taylor P., Chessler S.D.;
RT   "Expression of neurexin, neuroligin, and their cytoplasmic binding partners
RT   in the pancreatic beta-cells and the involvement of neuroligin in insulin
RT   secretion.";
RL   Endocrinology 149:6006-6017(2008).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18434543; DOI=10.1073/pnas.0801383105;
RA   Bolliger M.F., Pei J., Maxeiner S., Boucard A.A., Grishin N.V.,
RA   Sudhof T.C.;
RT   "Unusually rapid evolution of neuroligin-4 in mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:6421-6426(2008).
RN   [12]
RP   INTERACTION WITH NRXN1.
RX   PubMed=18334216; DOI=10.1016/j.str.2007.12.024;
RA   Koehnke J., Jin X., Trbovic N., Katsamba P.S., Brasch J., Ahlsen G.,
RA   Scheiffele P., Honig B., Palmer A.G. III, Shapiro L.;
RT   "Crystal structures of beta-neurexin 1 and beta-neurexin 2 ectodomains and
RT   dynamics of splice insertion sequence 4.";
RL   Structure 16:410-421(2008).
RN   [13]
RP   INTERACTION WITH NRXN1.
RX   PubMed=20624592; DOI=10.1016/j.neuron.2010.06.001;
RA   Koehnke J., Katsamba P.S., Ahlsen G., Bahna F., Vendome J., Honig B.,
RA   Shapiro L., Jin X.;
RT   "Splice form dependence of beta-neurexin/neuroligin binding interactions.";
RL   Neuron 67:61-74(2010).
RN   [14]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19914352; DOI=10.1016/j.neuroscience.2009.11.016;
RA   Levinson J.N., Li R., Kang R., Moukhles H., El-Husseini A., Bamji S.X.;
RT   "Postsynaptic scaffolding molecules modulate the localization of
RT   neuroligins.";
RL   Neuroscience 165:782-793(2010).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 46-638 IN COMPLEX WITH NRXN1,
RP   GLYCOSYLATION AT ASN-109 AND ASN-343, AND DISULFIDE BONDS.
RX   PubMed=18093522; DOI=10.1016/j.neuron.2007.12.002;
RA   Arac D., Boucard A.A., Ozkan E., Strop P., Newell E., Sudhof T.C.,
RA   Brunger A.T.;
RT   "Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex
RT   reveal specific protein-protein and protein-Ca2+ interactions.";
RL   Neuron 56:992-1003(2007).
CC   -!- FUNCTION: Cell surface protein involved in cell-cell-interactions via
CC       its interactions with neurexin family members. Plays a role in synapse
CC       function and synaptic signal transmission, and probably mediates its
CC       effects by recruiting and clustering other synaptic proteins. May
CC       promote the initial formation of synapses, but is not essential for
CC       this. In vitro, triggers the de novo formation of presynaptic
CC       structures. May be involved in specification of excitatory synapses.
CC       Required to maintain wakefulness quality and normal synchrony of
CC       cerebral cortex activity during wakefulness and sleep (By similarity).
CC       The protein is involved in nervous system development.
CC       {ECO:0000250|UniProtKB:Q99K10, ECO:0000269|PubMed:15620359,
CC       ECO:0000269|PubMed:9325340}.
CC   -!- SUBUNIT: Interacts with neurexins NRXN1, NRXN2 and NRXN3
CC       (PubMed:18334216, PubMed:20624592, PubMed:7736595, PubMed:8576240,
CC       PubMed:9325340). Interaction with neurexins is mediated by heparan
CC       sulfate glycan modification on neurexin (By similarity). Interacts with
CC       NLGN3. Interacts (via its C-terminus) with DLG4/PSD-95 (via PDZ domain
CC       3). Interacts with GOPC (By similarity). Interacts with AIP1 and
CC       PDZRN3. {ECO:0000250|UniProtKB:Q99K10, ECO:0000269|PubMed:15458844,
CC       ECO:0000269|PubMed:18093522, ECO:0000269|PubMed:18334216,
CC       ECO:0000269|PubMed:20624592, ECO:0000269|PubMed:7736595,
CC       ECO:0000269|PubMed:8576240, ECO:0000269|PubMed:9325340,
CC       ECO:0000269|PubMed:9694864}.
CC   -!- INTERACTION:
CC       Q62765; P97924-5: Kalrn; NbExp=5; IntAct=EBI-7281118, EBI-26961214;
CC       Q62765; F1M0Z1: Trio; NbExp=2; IntAct=EBI-7281118, EBI-26961238;
CC       Q62765-2; Q63373-3: Nrxn1; NbExp=5; IntAct=EBI-20994039, EBI-20994045;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Postsynaptic density {ECO:0000269|PubMed:18434543,
CC       ECO:0000269|PubMed:19914352, ECO:0000269|PubMed:9927700}. Synaptic
CC       cleft {ECO:0000269|PubMed:9927700}. Synaptic cell membrane
CC       {ECO:0000269|PubMed:9927700}. Note=Enriched in synaptic plasma
CC       membranes and clustered in synaptic clefts and postsynaptic densities.
CC       Colocalized with DLG4/PSD-95 and GRIN1/NMDAR1.
CC       {ECO:0000269|PubMed:19914352, ECO:0000269|PubMed:9927700}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q62765-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62765-2; Sequence=VSP_007531, VSP_007532;
CC       Name=3;
CC         IsoId=Q62765-3; Sequence=VSP_007532;
CC       Name=4;
CC         IsoId=Q62765-4; Sequence=VSP_007531;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, almost exclusively in neurons,
CC       and spinal chord. Detected in pancreas islet beta cells.
CC       {ECO:0000269|PubMed:11329178, ECO:0000269|PubMed:18755801,
CC       ECO:0000269|PubMed:19914352, ECO:0000269|PubMed:9927700}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low in embryonic brains (12 dpc to
CC       16 dpc) but increases dramatically after birth (postnatal days P0-P3)
CC       and reaches a plateau during the period when most synapses are formed
CC       (P5-P8). {ECO:0000269|PubMed:9927700}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U22952; AAA85720.1; -; mRNA.
DR   RefSeq; NP_446320.1; NM_053868.2. [Q62765-1]
DR   RefSeq; XP_017446072.1; XM_017590583.1. [Q62765-4]
DR   RefSeq; XP_017446073.1; XM_017590584.1.
DR   RefSeq; XP_017446074.1; XM_017590585.1.
DR   RefSeq; XP_017446075.1; XM_017590586.1.
DR   RefSeq; XP_017446076.1; XM_017590587.1.
DR   RefSeq; XP_017446077.1; XM_017590588.1.
DR   RefSeq; XP_017446078.1; XM_017590589.1.
DR   RefSeq; XP_017446079.1; XM_017590590.1. [Q62765-2]
DR   PDB; 3BIW; X-ray; 3.50 A; A/B/C/D=46-638.
DR   PDB; 3BIX; X-ray; 1.80 A; A/B/C/D=46-638.
DR   PDB; 3VKF; X-ray; 3.30 A; A/B=45-638.
DR   PDBsum; 3BIW; -.
DR   PDBsum; 3BIX; -.
DR   PDBsum; 3VKF; -.
DR   AlphaFoldDB; Q62765; -.
DR   SMR; Q62765; -.
DR   BioGRID; 250532; 12.
DR   ComplexPortal; CPX-4061; NLGN1(-SSA-SSB) - NRXN1-beta(-SS4) complex. [Q62765-2]
DR   ComplexPortal; CPX-4123; NLGN1(+SSA+SSB) - NRXN1-beta(-SS4) complex.
DR   DIP; DIP-44832N; -.
DR   IntAct; Q62765; 7.
DR   MINT; Q62765; -.
DR   STRING; 10116.ENSRNOP00000075793; -.
DR   ESTHER; ratno-1neur; Neuroligin.
DR   MEROPS; S09.994; -.
DR   GlyConnect; 433; 28 N-Linked glycans, 3 O-Linked glycans.
DR   GlyCosmos; Q62765; 6 sites, 60 glycans.
DR   GlyGen; Q62765; 7 sites, 54 N-linked glycans (1 site), 6 O-linked glycans (1 site).
DR   iPTMnet; Q62765; -.
DR   PhosphoSitePlus; Q62765; -.
DR   PaxDb; 10116-ENSRNOP00000049486; -.
DR   ABCD; Q62765; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000041111.3; ENSRNOP00000040172.3; ENSRNOG00000032576.7. [Q62765-1]
DR   Ensembl; ENSRNOT00000092660.2; ENSRNOP00000075793.2; ENSRNOG00000032576.7. [Q62765-4]
DR   Ensembl; ENSRNOT00055015804; ENSRNOP00055012683; ENSRNOG00055009326. [Q62765-1]
DR   Ensembl; ENSRNOT00060003701; ENSRNOP00060002566; ENSRNOG00060002354. [Q62765-1]
DR   Ensembl; ENSRNOT00065040474; ENSRNOP00065032969; ENSRNOG00065023630. [Q62765-1]
DR   GeneID; 116647; -.
DR   KEGG; rno:116647; -.
DR   UCSC; RGD:621117; rat. [Q62765-1]
DR   AGR; RGD:621117; -.
DR   CTD; 22871; -.
DR   RGD; 621117; Nlgn1.
DR   eggNOG; KOG1516; Eukaryota.
DR   GeneTree; ENSGT00940000155789; -.
DR   HOGENOM; CLU_006586_5_1_1; -.
DR   InParanoid; Q62765; -.
DR   OMA; SLHPHDM; -.
DR   OrthoDB; 4386at2759; -.
DR   PhylomeDB; Q62765; -.
DR   TreeFam; TF326187; -.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   EvolutionaryTrace; Q62765; -.
DR   PRO; PR:Q62765; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000032576; Expressed in frontal cortex and 7 other cell types or tissues.
DR   ExpressionAtlas; Q62765; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; IDA:BHF-UCL.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:BHF-UCL.
DR   GO; GO:0060076; C:excitatory synapse; NAS:ComplexPortal.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0032433; C:filopodium tip; IDA:BHF-UCL.
DR   GO; GO:0098982; C:GABA-ergic synapse; NAS:ComplexPortal.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0060077; C:inhibitory synapse; NAS:ComplexPortal.
DR   GO; GO:0031594; C:neuromuscular junction; NAS:ComplexPortal.
DR   GO; GO:0098984; C:neuron to neuron synapse; NAS:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:BHF-UCL.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0098635; C:protein complex involved in cell-cell adhesion; IPI:ComplexPortal.
DR   GO; GO:0043235; C:receptor complex; ISS:BHF-UCL.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0043083; C:synaptic cleft; IEA:UniProtKB-SubCell.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0042043; F:neurexin family protein binding; IPI:ARUK-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:0097113; P:AMPA glutamate receptor clustering; IMP:BHF-UCL.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0090125; P:cell-cell adhesion involved in synapse maturation; NAS:ComplexPortal.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:ARUK-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0048789; P:cytoskeletal matrix organization at active zone; IMP:BHF-UCL.
DR   GO; GO:0045184; P:establishment of protein localization; ISS:BHF-UCL.
DR   GO; GO:1904861; P:excitatory synapse assembly; ISO:RGD.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0099558; P:maintenance of synapse structure; NAS:ComplexPortal.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IMP:ARUK-UCL.
DR   GO; GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0097115; P:neurexin clustering involved in presynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0140058; P:neuron projection arborization; IGI:ARUK-UCL.
DR   GO; GO:0031175; P:neuron projection development; IGI:ARUK-UCL.
DR   GO; GO:0048812; P:neuron projection morphogenesis; NAS:ComplexPortal.
DR   GO; GO:0045161; P:neuronal ion channel clustering; TAS:UniProtKB.
DR   GO; GO:0097114; P:NMDA glutamate receptor clustering; IDA:BHF-UCL.
DR   GO; GO:0010841; P:positive regulation of circadian sleep/wake cycle, wakefulness; ISS:UniProtKB.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IDA:BHF-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL.
DR   GO; GO:1902533; P:positive regulation of intracellular signal transduction; IDA:BHF-UCL.
DR   GO; GO:1900075; P:positive regulation of neuromuscular synaptic transmission; NAS:ComplexPortal.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; NAS:ComplexPortal.
DR   GO; GO:1905520; P:positive regulation of presynaptic active zone assembly; IDA:BHF-UCL.
DR   GO; GO:1902474; P:positive regulation of protein localization to synapse; IMP:RGD.
DR   GO; GO:1900029; P:positive regulation of ruffle assembly; IDA:BHF-UCL.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IDA:BHF-UCL.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:BHF-UCL.
DR   GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; ISO:RGD.
DR   GO; GO:1900244; P:positive regulation of synaptic vesicle endocytosis; IMP:BHF-UCL.
DR   GO; GO:2000302; P:positive regulation of synaptic vesicle exocytosis; IMP:BHF-UCL.
DR   GO; GO:0097119; P:postsynaptic density protein 95 clustering; IDA:BHF-UCL.
DR   GO; GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0098698; P:postsynaptic specialization assembly; ISO:RGD.
DR   GO; GO:0097105; P:presynaptic membrane assembly; IDA:BHF-UCL.
DR   GO; GO:0035418; P:protein localization to synapse; ISS:BHF-UCL.
DR   GO; GO:0006605; P:protein targeting; IDA:UniProtKB.
DR   GO; GO:0097120; P:receptor localization to synapse; ISS:BHF-UCL.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; IDA:BHF-UCL.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; IDA:BHF-UCL.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; ISO:RGD.
DR   GO; GO:0099174; P:regulation of presynapse organization; IDA:SynGO.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; ISO:RGD.
DR   GO; GO:0098942; P:retrograde trans-synaptic signaling by trans-synaptic protein complex; IMP:SynGO.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0007416; P:synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0060074; P:synapse maturation; NAS:ComplexPortal.
DR   GO; GO:0050808; P:synapse organization; IDA:MGI.
DR   GO; GO:0099560; P:synaptic membrane adhesion; ISO:RGD.
DR   GO; GO:0097091; P:synaptic vesicle clustering; IDA:BHF-UCL.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0016080; P:synaptic vesicle targeting; ISS:UniProtKB.
DR   GO; GO:0048489; P:synaptic vesicle transport; IMP:CACAO.
DR   GO; GO:0072553; P:terminal button organization; IMP:BHF-UCL.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR051093; Neuroligin/BSAL.
DR   InterPro; IPR000460; Nlgn.
DR   PANTHER; PTHR43903; NEUROLIGIN; 1.
DR   PANTHER; PTHR43903:SF2; NEUROLIGIN-1; 1.
DR   Pfam; PF00135; COesterase; 1.
DR   PRINTS; PR01090; NEUROLIGIN.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Biological rhythms; Cell adhesion;
KW   Cell membrane; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Membrane; Reference proteome; Secreted; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..45
FT                   /evidence="ECO:0000255"
FT   CHAIN           46..843
FT                   /note="Neuroligin-1"
FT                   /id="PRO_0000008642"
FT   TOPO_DOM        46..697
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        698..718
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        719..843
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          647..688
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          822..843
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        109
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18093522"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14769026"
FT   CARBOHYD        343
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18093522"
FT   CARBOHYD        547
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14769026"
FT   CARBOHYD        683
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:14769026"
FT   CARBOHYD        686
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:14769026"
FT   DISULFID        117..153
FT   DISULFID        172..181
FT   DISULFID        342..353
FT   DISULFID        512..546
FT   VAR_SEQ         165..184
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:7736595"
FT                   /id="VSP_007531"
FT   VAR_SEQ         298..306
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7736595"
FT                   /id="VSP_007532"
FT   STRAND          54..57
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          65..67
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          70..74
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          77..84
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          105..109
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   TURN            128..130
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           133..136
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           139..145
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          146..149
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          155..161
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           169..174
FT                   /evidence="ECO:0007829|PDB:3VKF"
FT   HELIX           179..182
FT                   /evidence="ECO:0007829|PDB:3VKF"
FT   STRAND          193..198
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          202..206
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           209..211
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           215..221
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          224..228
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           233..237
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          241..244
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           249..264
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           265..268
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          270..280
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           282..291
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           294..296
FT                   /evidence="ECO:0007829|PDB:3VKF"
FT   STRAND          311..316
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          319..321
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           329..340
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           347..354
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           359..363
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          375..377
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           389..394
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          402..408
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   TURN            409..412
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           413..416
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   TURN            417..419
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           428..443
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          445..448
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           452..459
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           463..465
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           469..484
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           486..498
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          503..508
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          515..517
FT                   /evidence="ECO:0007829|PDB:3VKF"
FT   TURN            525..528
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           529..532
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           535..538
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          542..544
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           550..569
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          574..576
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           582..584
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   TURN            589..592
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   TURN            600..602
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          604..611
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   STRAND          613..617
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           620..627
FT                   /evidence="ECO:0007829|PDB:3BIX"
FT   HELIX           629..634
FT                   /evidence="ECO:0007829|PDB:3BIX"
SQ   SEQUENCE   843 AA;  94294 MW;  90A18540245B789D CRC64;
     MALPRCMWPN YVWRAMMACV VHRGSGAPLT LCLLGCLLQT FHVLSQKLDD VDPLVTTNFG
     KIRGIKKELN NEILGPVIQF LGVPYAAPPT GEHRFQPPEP PSPWSDIRNA TQFAPVCPQN
     IIDGRLPEVM LPVWFTNNLD VVSSYVQDQS EDCLYLNIYV PTEDVKRISK ECARKPGKKI
     CRKGDIRDSG GPKPVMVYIH GGSYMEGTGN LYDGSVLASY GNVIVITVNY RLGVLGFLST
     GDQAAKGNYG LLDLIQALRW TSENIGFFGG DPLRITVFGS GAGGSCVNLL TLSHYSEGNR
     WSNSTKGLFQ RAIAQSGTAL SSWAVSFQPA KYARILATKV GCNVSDTVEL VECLQKKPYK
     ELVDQDVQPA RYHIAFGPVI DGDVIPDDPQ ILMEQGEFLN YDIMLGVNQG EGLKFVENIV
     DSDDGVSASD FDFAVSNFVD NLYGYPEGKD VLRETIKFMY TDWADRHNPE TRRKTLLALF
     TDHQWVAPAV ATADLHSNFG SPTYFYAFYH HCQTDQVPAW ADAAHGDEVP YVLGIPMIGP
     TELFPCNFSK NDVMLSAVVM TYWTNFAKTG DPNQPVPQDT KFIHTKPNRF EEVAWTRYSQ
     KDQLYLHIGL KPRVKEHYRA NKVNLWLELV PHLHNLNDIS QYTSTTTKVP STDITLRPTR
     KNSTPVTSAF PTAKQDDPKQ QPSPFSVDQR DYSTELSVTI AVGASLLFLN ILAFAALYYK
     KDKRRHDVHR RCSPQRTTTN DLTHAPEEEI MSLQMKHTDL DHECESIHPH EVVLRTACPP
     DYTLAMRRSP DDVPLMTPNT ITMIPNTIPG IQPLHTFNTF TGGQNNTLPH PHPHPHSHST
     TRV
//
